After 50 Years, the FDA Finds Out Oral
Jeffrey A. Singer On September 12, a Food and Drug Administration advisory panel reported that oral phenylephrine hydrochloride, an ingredient in
U.S. Food Aid for Poor Countries
Chris Edwards and Krit Chanwong Congress is scheduled to reauthorize farm programs this fall, which provides an opportunity to cut
Introducing Defending Globalization, a new Cato Institute Project
Scott Lincicome Today we’re launching a new multi‐year, multimedia Cato project — Defending Globalization. The last few years have witnessed renewed
Dollarization’s Critics Are Ignoring the Evidence
Daniel Raisbeck and Gabriela Calderon de Burgos After paying little attention to dollarization in Latin America for over two decades,
San Francisco Loses Tens of Millions of Dollars
Marc Joffe If you’ve visited San Francisco recently, you know that a ride on the city’s famous cable cars is not
Google’s Antitrust Trial Starts: What’s at Stake and
Jennifer Huddleston The antitrust cases against Google brought by the Department of Justice (DOJ) and several state attorneys general begin
Time for Pandemic Emergency Spending to End
David Boaz New exercises of federal spending power are often justified on the basis of some emergency. Both the Hoover
A Backlash Against First Amendment Standing?
Walter Olson When the Supreme Court ruled 6–3 this June in 303 Creative LLC v. Elenis that Colorado could not
Is the DC Department of Health Embarking on
Jeffrey A. Singer The District of Columbia Department of Health recently posted a message on “X” to get residents to abandon
The U.S. Experience in Colombia Is a Terrible
Justin Logan Friday afternoon, Daniel Raisbeck and I published a longish article in Foreign Policy magazine throwing cold water on the idea